Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to compare regional amyloid burden in Parkinson's disease
(PD) to normal control subjects. We hypothesize that there will be significant differences in
overall amyloid burden in PD patients compared to age-matched normal controls.
Phase:
Phase 2
Details
Lead Sponsor:
Avid Radiopharmaceuticals
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH)